The Knowledge Hub

Scientific Abstract: This technical review details structural variations between CJC-1295 with Drug Affinity Complex (DAC) and its non-DAC counterpart, Modified GRF (1-29). Both agents are synthetic Growth Hormone-Releasing Hormone (GHRH) analogues, engineered to bind pituitary somatotroph receptors…

Cytoskeletal assembly and cellular migration dictate fundamental eukaryotic biology. Thymosin Beta-4 (Tβ4) functions as the principal actin-sequestering molecule within these systems. TB-500, a synthetic analogue, replicates the parent protein's active domain to isolate cellular mechanics durin…

Endocrine research frequently targets the hypothalamic-pituitary-somatotropic axis to map regulatory pathways. Growth hormone-releasing hormone (GHRH) operates as the primary stimulatory ligand here, originating in the hypothalamus before interacting with anterior pituitary cells. While native GHRH…

Regulating experimental variables is mandatory when analysing growth hormone-releasing hormone (GHRH) analogues via cellular assays. Tesamorelin features distinct structural modifications that heavily influence its in-vitro stability and receptor affinity. Technicians designing high-throughput labor…

Modified analogues of endogenous Growth Hormone-Releasing Hormone (GHRH), such as tesamorelin, permit investigators to isolate specific endocrine mechanisms during in-vitro cellular assays. This 44-amino acid peptide features a distinct structural alteration at its N-terminus: the covalent attachmen…